Does TOCILIZUMAB Cause Product use in unapproved indication? 2,923 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,923 reports of Product use in unapproved indication have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 3.0% of all adverse event reports for TOCILIZUMAB.
2,923
Reports of Product use in unapproved indication with TOCILIZUMAB
3.0%
of all TOCILIZUMAB reports
1,236
Deaths
1,592
Hospitalizations
How Dangerous Is Product use in unapproved indication From TOCILIZUMAB?
Of the 2,923 reports, 1,236 (42.3%) resulted in death, 1,592 (54.5%) required hospitalization, and 1,352 (46.3%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 2,923 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which TOCILIZUMAB Alternatives Have Lower Product use in unapproved indication Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE